brokerbase

About tradingpattern.net

The movement of a security's price over a specific time period.

dedicated to value creation and applying the scientific method in finance

Search


www.brokerbase.ch network - market statistics - weekly update

www.brokerbase.ch High dividend yield stocks

www.brokerbase.ch network

3M Activision Blizzard Adobe Systems Affimetrix Airlines Akamai Tech Alcoa Altera Amazon.com American Express American Tower Amgen Amylin Pharma Analyst Rating AngloGold Apollo Group Apple Applied Materials AT&T Autodesk Automatic Data Processing Baidu Bank of America Baxter Bed Bath & Beyond Blackrock Boeing Broadcom C.H. Robinson CA Caterpillar Celgene Cephalon Charts Check Point Software Chevron Cintas Corporation Cisco Systems Citigroup Citrix Coca Cola Cognizant Comcast Costco Wholesale Cree Dell DENTSPLY DIRECTV Discount, Variety Stores DISH Disney Dow 30 Downgrade Dr. Reddy's Laboratories Du Pont eBay Electronic Arts EMC Corporation Expedia Expeditors Express Scripts Extreme Networks Exxon Mobil FANNIE MAE Fastenal First Solar Fiserv Flextronics FLIR Ford Foster Wheeler FREDDIE MAC Freeport-McMoRan Garmin Genentech General Electric Genzyme Gilead Sciences Golden Star Resources Goldman Sachs Google Hansen Natural Hardware Healthcare Hecla Mining Henry Schein Hewlett Packard Hologic Home Depot Human Genome Science Hunt Transport IBM Illumina Industry Infosys Initial Recommendation Intel InterActive Corp Intuit Intuitive Surgical Johnson & Johnson Joy Global JP Morgan Juniper Networks KKR KLA-Tencor Kraft Foods Lam Research Level 3 Liberty Global Liberty Media Life Technologies Linear Technology Lockheed Martin Logitech Marvell Technology MasterCard Maxim Integrated McDonalds Merck Merril Lynch Microchip Technology Microsoft Millicom Morgan Stanley Nasdaq 100 NetApp NETFLIX Network Network Appliance Newmont Mining News Corporation NII Holdings Noble NVIDIA O'Reilly Automotive Occidental Petroleum Oracle PACCAR Patterson Paychex Petrohawk PETROLEO BRASILEIRO Pfizer Pharmaceutical Product Development Procter & Gamble Qualcomm Quanta Renhe Commercial Holdings Research in Motion Riverbed Technology Ross Stores Royal Gold Ryanair S&P 500 salesforce.com SanDisk Seagate Sears Holdings Semiconductor - Integrated Circuits Services Sigma-Aldrich Software Southwest Airlines Staples Starbucks Steel & Iron Steel Dynamics Stericycle Symantec Synaptics Technology Teva Texas Instruments Ticker Travelers Uncategorized United Continental Holdings United Technologies Upgrade Urban Outfitters VeriSign Verizon Vertex Pharmaceuticals Visa Wal Mart Warner Chilcott Wells Fargo Wynn Resorts Xilinx XTO Yahoo Zoltek

www.brokerbase.ch network - archived market statistics

Blogroll

Recent Posts

Gilead Sciences

« Previous Entries

Gilead Sciences (GILD) Upgrade from Hold to Buy – Analyst rating from Argus

Thursday, June 13th, 2013

Gilead Sciences to Present at the Cowen & Company 33rd Annual Health Care Conference on Monday, March 4

Sunday, March 3rd, 2013

Gilead Sciences to Present at the Cowen & Company 33rd Annual Health Care Conference on Monday, March 4

Saturday, March 2nd, 2013

Gilead Sciences Completes Acquisition of YM BioSciences

Sunday, February 10th, 2013

Has Gilead Sciences Become the Perfect Stock?

Sunday, February 10th, 2013

Gilead Sciences kaufen – New Analyst Rating from boerse.de-Aktienbrief

Monday, January 14th, 2013

Gilead Sciences kaufen – New Analyst Rating from Aktienservice Research

Friday, January 11th, 2013

Gilead Sciences kaufen – New Analyst Rating from boerse.de-Aktienbrief

Friday, January 11th, 2013

Gilead Sciences overweight – New Analyst Rating from Piper Jaffray & Co.

Monday, December 3rd, 2012

Gilead Sciences outperform – New Analyst Rating from RBC Capital Markets

Friday, November 16th, 2012

Gilead Sciences outperform – New Analyst Rating from RBC Capital Markets

Thursday, November 15th, 2012

Gilead Sciences buy – New Analyst Rating from Stifel, Nicolaus & Co., Inc.

Wednesday, November 14th, 2012

Gilead Sciences buy – New Analyst Rating from Deutsche Bank Securities

Wednesday, November 14th, 2012

Gilead Sciences buy – New Analyst Rating from Stifel, Nicolaus & Co., Inc.

Tuesday, November 13th, 2012

Gilead Sciences neutral – New Analyst Rating from Credit Suisse Group

Tuesday, November 13th, 2012

Gilead Sciences buy – New Analyst Rating from UBS AG

Wednesday, October 3rd, 2012

Gilead Sciences buy – New Analyst Rating from UBS AG

Friday, August 31st, 2012

Gilead Sciences buy – New Analyst Rating from UBS AG

Thursday, August 30th, 2012

Gilead Sciences overweight – New Analyst Rating from JP Morgan Chase & Co.

Monday, August 20th, 2012

Gilead Sciences buy – New Analyst Rating from Citigroup Corp.

Friday, August 17th, 2012

Gilead Sciences outperform – New Analyst Rating from RBC Capital Markets

Monday, July 16th, 2012

Gilead Sciences outperform – New Analyst Rating from RBC Capital Markets

Thursday, July 12th, 2012

Gilead Sciences outperform – New Analyst Rating from RBC Capital Markets

Friday, June 29th, 2012

Gilead Sciences outperform – New Analyst Rating from RBC Capital Markets

Monday, June 25th, 2012

Gilead Sciences outperform – New Analyst Rating from RBC Capital Markets

Friday, June 22nd, 2012

Gilead Sciences outperform – New Analyst Rating from RBC Capital Markets

Wednesday, June 20th, 2012

Gilead Sciences outperform – New Analyst Rating from RBC Capital Markets

Tuesday, June 19th, 2012

Gilead Sciences kaufen – New Analyst Rating from Der Aktionaer

Friday, May 25th, 2012

Gilead Sciences outperform – New Analyst Rating from Needham & Company, LLC

Monday, April 30th, 2012

Gilead Sciences buy – New Analyst Rating from Citigroup Corp.

Monday, April 30th, 2012

Gilead Sciences outperform – New Analyst Rating from RBC Capital Markets

Wednesday, March 21st, 2012

Gilead Sciences outperform – New Analyst Rating from RBC Capital Markets

Tuesday, March 20th, 2012

Gilead Sciences buy – New Analyst Rating from Stifel, Nicolaus & Co., Inc.

Friday, March 16th, 2012

Gilead Sciences overweight – New Analyst Rating from JP Morgan Chase & Co.

Friday, February 24th, 2012

Gilead Sciences outperform – New Analyst Rating from RBC Capital Markets

Thursday, February 23rd, 2012

Gilead Sciences outperform – New Analyst Rating from RBC Capital Markets

Friday, February 17th, 2012

Gilead Sciences outperform – New Analyst Rating from RBC Capital Markets

Thursday, February 16th, 2012

Gilead Sciences outperform – New Analyst Rating from RBC Capital Markets

Monday, February 6th, 2012

Gilead Sciences outperform – New Analyst Rating from Robert W. Baird & Co. Incorporated

Monday, February 6th, 2012

Gilead Sciences buy – New Analyst Rating from Needham & Company, LLC

Monday, February 6th, 2012

Gilead Sciences buy – New Analyst Rating from Deutsche Bank Securities

Monday, February 6th, 2012

Gilead Sciences outperform – New Analyst Rating from RBC Capital Markets

Wednesday, January 25th, 2012

Gilead Sciences outperform – New Analyst Rating from RBC Capital Markets

Friday, January 20th, 2012

Gilead Sciences buy – New Analyst Rating from Needham & Company, LLC

Monday, January 9th, 2012

Gilead Sciences neutral – New Analyst Rating from Credit Suisse Group

Monday, December 12th, 2011 « Previous Entries